Pharmacology - Perfusion and Clotting Review

Cardiovascular Drugs

Drug Classes, Suffixes, and Examples

ClassSuffixExamples
Beta-blockers-ololPropanolol, atenolol
ACE inhibitors-prilLisinopril, captopril
Calcium channel blockers-pine/ -amilverapamil
Angiotensin II receptor antagonists (ARBS)-sartanLosartan, valsartan
Anticoagulants (Factor Xa inhibitors)-xabanApixaban
Low-molecular-weight-heparin (LMWH)-parinHeparin
Thrombolytics-teplase/ aseAlteplase
Antiarrhythmics-aroneAmiodarone, dronedarone

Antihypertensives: Beta Blockers

Mechanism of Action (MOA)

  • Decreases heart rate (HR).
  • Reduces secretion of renin.
  • Long-term use causes reduced peripheral vascular resistance (PVR).

Indications

  • Hypertension (HTN), Angina, Dysrhythmias, and Myocardial Infarction (MI) - Cardioprotective effects
  • Migraine headaches
  • Essential tremors and stage fright
  • Decreases heart rate, resulting in decreased myocardial oxygen demand and increased oxygen delivery to the heart
  • Prophylactic treatment for angina

Contraindications

  • Asthma, because it can cause bronchoconstriction
  • Systolic Heart Failure (HF)
  • Serious conduction disturbances
  • Diabetes Mellitus Type II (DM II): Can mask hypoglycemia-induced tachycardia.
  • Peripheral Vascular Disease (PVD): May further compromise cerebral or peripheral blood flow.

Adverse Effects

  • Bradycardia, hypotension
  • Atrioventricular (AV) block
  • Hyperglycemia or hypoglycemia
  • Hyperlipidemia
  • Dizziness, fatigue, depression, lethargy
  • Impotence, wheezing, dyspnea

Nursing Considerations

  • Clients should monitor their pulse rates daily and report a rate below 60 beats/min or symptoms of bradycardia.
  • Hold medication if systolic BP is less than 100 mm Hg.
  • Instruct patients to report dizziness or fainting.
  • Inform patients that these medications should never be abruptly discontinued.
  • Inform patients that these medications are for long-term prevention of angina, not for immediate relief.

Calcium Channel Blockers

Mechanism of Action (MOA)

  • Cause smooth muscle relaxation by blocking the binding of calcium, preventing muscle contraction.
  • Causes coronary artery vasodilation.
  • Reduces the workload of the heart.
  • Decreases blood pressure (BP).

Indications

  • Hypertension (HTN) - Amlodipine.
  • Angina
  • Dysrhythmias
  • Migraine headaches
  • Raynaud’s disease
  • Decreases heart rate, resulting in decreased myocardial oxygen demand and increased oxygen delivery to the heart

Contraindications

  • Known drug allergy
  • Acute MI
  • Second- or third-degree AV block (unless the patient has a pacemaker)
  • Hypotension

Adverse Effects

  • Hypotension
  • Palpitations
  • Tachycardia or bradycardia
  • Constipation, nausea, dyspnea

Nursing Considerations

  • Constipation is a common problem; instruct patients to take in adequate fluids and eat high-fiber foods.
  • Avoid hot tubs and jacuzzis because this causes hypotensive effects.
  • Hold dose if systolic BP is less than 100.

ACE Inhibitors

Mechanism of Action (MOA)

  • Interferes with the renin-angiotensin-aldosterone system (RAAS).
  • Induces aldosterone secretion by the adrenal glands.

Indications

  • Hypertension (HTN)
  • Heart Failure (HF)
  • Renal protective effects in DM
  • Decreases heart rate, resulting in decreased myocardial oxygen demand and increased oxygen delivery to the heart

Contraindications

  • Systolic Heart Failure (HF)
  • Serious conduction disturbances
  • Asthma patients because any level of blockade can cause bronchoconstriction.
  • Diabetes Mellitus Type II (DM II): Can mask hypoglycemia-induced tachycardia.
  • Peripheral Vascular Disease (PVD): May further compromise cerebral or peripheral blood flow.

Adverse Effects

  • Angioedema - wheezing, stridor, dyspnea
    • Assess the airway
    • Call emergency response team
    • Apply high-flow O_2
    • Initiate IV access if not in place already
    • Administer epinephrine if anaphylaxis is the cause
    • Administer IV antihistamines
  • Hyperkalemia
  • Dry non-productive cough
  • Fatigue, Dizziness, headache, Mood changes, Impaired taste.

ARBs - Angiotensin II Receptor Blockers

Mechanism of Action (MOA)

  • Blocks the binding of angiotensin II to the type 1 receptors.
  • Blocks vasoconstriction and the secretion of aldosterone.

Indications

  • Hypertension (HTN)
  • Heart failure

Contraindications

  • Renal or hepatic dysfunction
  • Breastfeeding or pregnancy

Adverse Effects

  • Chest pain, fatigue, hypoglycemia, diarrhea, UTI, anemia, weakness, hyperkalemia.

Nursing Considerations

  • Monitor for hypotension
  • DO not use with ibuprofen because it enhances hypotension

Nitrates/Nitrites

Mechanism of Action (MOA)

  • Causes vasodilation.
  • Relaxes smooth muscle to help with dilation of the coronary arteries.

Indications

  • Angina
  • Treatment of HF
  • Acute MI
  • Hypertensive emergencies

Contraindications

  • Known drug allergy
  • Severe anemia
  • Closed-angle glaucoma
  • Hypotension
  • Severe head injury
  • Use of the erectile dysfunction drugs sildenafil (Viagra), tadalafil (Cialis), and vardenafil (Levitra)

Adverse Effects

  • Headaches - Expected, usually diminish in intensity and frequency with continued use
  • Reflex tachycardia
  • Postural hypotension
  • Skin irritation with topical application

Nursing Considerations

  • Instruct patients never to chew or swallow the sublingual form.
  • Instruct patients to keep a fresh supply of sublingual medication on hand; potency is lost in about 3 months after the bottle has been opened.
  • To preserve potency, medications should be stored in an airtight, dark glass bottle with a metal cap and no cotton filler.
  • Instruct patients in the proper application of nitrate topical ointments and transdermal forms, including site rotation and removal of old medication.
  • To reduce tolerance, the patient may be instructed to remove topical forms at bedtime and apply new doses in the morning, allowing for a nitrate-free period.
  • Transdermal patches can be applied for 12-14 hours and then take a break while sleeping!!
  • During acute angina event!
    • Stop activity and sit or lie down and take a sublingual tablet.
    • If there is no relief in 5 minutes, call 911 or emergency services immediately and take a second sublingual tablet.
    • If there is no relief in 5 minutes, take a third sublingual tablet.

Vasodilators - Diazoxide, Hydralazine, Monoxidil, Nitroprusside

Mechanism of Action (MOA)

  • Relax arteriolar or venous smooth muscle and decreases SVR, afterload, and peripheral vasodilation.

Indications

  • Hypertension

Contraindications

  • Allergy
  • Hypotension
  • Cerebral edema, head injury
  • Acute MI or CAD
  • Nitroprusside BLACK BOX WARNING - hypotension and cyanide toxicity

Adverse Effects

  • Hydralazine: dizziness, headache, anxiety, tachycardia, edema, dyspnea, nausea, vomiting, diarrhea, hepatitis, systemic lupus erythematosus, vitamin B_6 deficiency, and rash
  • Minoxidil: T-wave electrocardiographic changes, pericardial effusion or tamponade, angina, breast tenderness, rash, and thrombocytopenia
  • Sodium nitroprusside: bradycardia, decreased platelet aggregation, rash, hypothyroidism, hypotension, methemoglobinemia, and (rarely) cyanide toxicity

Nursing Considerations

  • Monitor for Hypotension

Digoxin

Mechanism of Action

  • Control ventricular response to atrial fibrillation

Indications

  • Heart Failure

Contraindications

  • Hypersensitivity
  • Ventricular tachycardia
  • Atrial fibrillation

Adverse Effects

  • Cardiovascular: dysrhythmias, including bradycardia or tachycardia
  • Central nervous system: headaches, fatigue, malaise, confusion, convulsions
  • Eyes: colored vision (seeing green, yellow, purple), halo vision, flickering lights
  • Gastrointestinal: anorexia, nausea, vomiting, diarrhea
  • Digoxin Toxicity: Visual disturbances, N, V, anorexia, abdominal discomfort, fatigue.

Nursing Considerations

  • Digoxin has a very narrow therapeutic window
  • Drug levels must be monitored - Therapeutic level = 0.5-2 mg/mL
  • Low Potassium levels increase the risk for digoxin toxicity - Electrolytes must be closely monitored
  • Monitor for S/S of digoxin toxicity; if present, hold medication and report findings to the provider.
  • Antidote: Digoxin Immune Fab(Digibind)

Amiodarone

Mechanism of Action

  • Control ventricular response to atrial fibrillation

Indications

  • Dysrhythmias - Supraventricular and ventricular

Contraindications

  • Hypersensitivity, iodine allergy
  • Severe sinus bradycardia; second- or third-degree heart block
  • Warfarin and Digoxin: Digoxin levels increase by 50% and INR increases by 50%

Adverse Effects

  • Corneal microdeposits: Halos, photophobia, dry eyes - Most common adverse effect!
  • Hypothyroidism/Hyperthyroidism
  • Dysrhythmias
  • Hepatotoxicity
  • Pulmonary toxicity

Nursing Considerations

  • Monitor for S/S of hypo/hyperthyroidism
  • Monitor for dysrhythmias
  • Monitor AST/ALT levels - Hepatic function
  • Avoid grapefruit juice
  • Obtain baseline ECG
  • Amiodarone has a BLACK BOX WARNING

Coagulation Modifier Drugs: Heparin

Mechanism of Action (MOA)

  • Inhibit clotting factors Thrombin and Xa

Indications

  • Prevention of blood clots

Contraindications

  • Hypersensitivity
  • Uncontrolled bleeding
  • HIT
  • Severe thrombocytopenia or open wounds

Adverse Effects

  • Alopecia, rash, urticaria
  • Bleeding
  • HIT

Nursing Considerations

  • Do not give subcutaneous doses within 2 inches of: umbilicus, abdominal incisions, open wounds, scars, drainage tubes, or stomas
  • Do not aspirate subcutaneous injections or massage the injection site - Hematoma formation
  • IV doses are double-checked with another nurse.
  • Subcutaneous doses should be given in areas of deep subcutaneous fat and sites rotated.
  • DVT prophylaxis: 5000 units subcutaneously 2-3x/day; does not need to be monitored
  • Monitor aPTT - every 6 hrs until therapeutic effect is evaluated
  • aPTT= ABOUT 60 secs.
  • aPTT= 1.5-2
  • Antidote: Protamine sulfate

Warfarin

Mechanism of Action (MOA)

  • Inhibits production of vitamin K-dependent clotting factors II, VII, IX, and X, which are synthesized in the liver

Indications

  • Prevents blood clot formation

Contraindications

  • Hypersensitivity
  • Uncontrolled bleeding or open wounds
  • Uncontrolled HTN
  • Pregnancy

Adverse Effects

  • Dermal necrosis, bleeding, fever

Nursing Considerations

  • Avoid alcohol, NSAIDs, and aspirin
  • Use electric razors
  • It can be started while the client is on heparin until PT/INR levels indicate adequate anticoagulation - Therapeutic effect takes several days
  • Monitor PT/INR regularly - INR without warfarin = 1, with warfarin = 2-3.5
  • Avoid vitamin K products: Leafy green vegetables, strawberries, raisins, cantaloupe, potatoes
  • Interactions: Amiodarone, fluconazole, erythromycin, metronidazole, sulfonylureas
  • Amiodarone + warfarin = Warfarin dose decreased in ½
  • Avoid supplements: garlic, gingko, St. John’s wort
  • Antidote: Vitamin K

Factor Xa Drugs - Rivaroxaban

Indications

  • Prevention of stroke
  • Treatment of DVT and PE

Contraindications

  • Hypersensitivity
  • Severe renal impairment
  • Active bleeding

Adverse Effects

  • Peripheral edema
  • Dizziness, headache, diarrhea
  • Hematuria, bleeding, bruising

Nursing Considerations

  • Assess for signs of bleeding and hemorrhage
  • Bleeding from surgical sites
  • No routine labs are required - May falsely elevate INR
  • Cannot be given with another anticoagulant

Direct Thrombin Inhibitor - Dabigatran

Indications

  • Prevention of stroke and thrombosis

Contraindications

  • Hypersensitivity
  • Active bleeding
  • Pregnancy

Adverse Effects

  • Hypersensitivity reaction
  • Bleeding; increased GI bleeding

Nursing Considerations

  • Monitor renal function - Dose is adjusted according to these levels
  • No coagulation monitoring is required
  • Interactions: phenytoin, rifampin, St. John’s Wort
  • Antidote: Idarucizumab (Praxbind)

Antiplatelets - Clopidogrel

Mechanism of Action (MOA)

  • Inhibits platelet aggregation by irreversibly inhibiting the binding of ATP to platelet receptors

Indications

  • Decreases risk of MI and stroke

Contraindications

  • Hypersensitivity
  • Bleeding
  • Concurrent use with omeprazole
  • Lactation

Adverse Effects

  • Steven-Johnson Syndrome
  • GI bleeding, neutropenia, thrombocytopenia, leukemia
  • GI ulcers
  • Vitamin K deficiency
  • Flu-like symptoms

Nursing Considerations

  • Monitor for S/S of thrombocytopenia, hemolytic anemia, purpura
  • Monitor bleeding time drug therapy or prolonged bleeding time
  • Monitor CBC with differential and platelet count
  • Stop medication 5 days before surgery
  • Decreased effect: Amiodarone, Calcium-channel blockers, NSAIDs, PPI

Thrombolytics - Alteplase

Mechanism of Action (MOA)

  • Converts plasminogen to plasmin, which breaks down or lyses the thrombus. Clot buster

Indication

  • Clot buster

Contraindications

  • Hypersensitivity
  • Active internal bleeding
  • CVA or aneurysm

Adverse Effects

  • Intracranial hemorrhage
  • GU tract or GI bleeding
  • Anaphylaxis
  • N,V, Hypotension

Nursing Considerations

  • Monitor for bleeding gums, mucous membranes, or injection sites.

Antiplatelet - Aspirin

Indications

  • Thrombotic stroke prevention

Contraindications

  • Children and teenagers with flu-like symptoms - Reye’s syndrome (swelling of the brain or liver)
  • Concurrent use with gingko - Increases bleeding
  • PUD

Nursing Considerations

  • Assess for bleeding, ulcers
  • Administer with food to decrease gastric irritation

Antilipemic Drugs - HMG-CoA Reductase Inhibitors

Mechanism of Action (MOA)

  • Decreases production of LDL, increases production of HDL

Indications

  • Hypercholesterolemia, prevention of CAD

Adverse Effects

  • Hepatotoxicity
  • GI upset
  • Muscle pain
  • Rhabdomyolysis

Nursing Considerations

  • Administer with evening meal
  • Monitor liver function and CK levels
  • Avoid alcohol
  • Avoid grapefruit juice

Diuretic Drugs - Furosemide

Indications

  • Pulmonary edema
  • Edema associated with HF
  • Liver disease - Ascites
  • Nephrotic syndrome
  • HTN

Contraindications

  • Allergy/ Allergy to sulfonamide antibiotics
  • Hepatic coma
  • Severe electrolyte loss

Adverse effects

  • Dizziness, headache, N,V,D
  • Tinnitus
  • Agranulocytosis - Neutropenia, thrombocytopenia
  • Hypokalemia, hyperglycemia, hyperuricemia

Nursing Considerations

  • It increases serum levels of uric acid and glucose
  • Additive effect to aminoglycosides and vancomycin - Ototoxicity and neurotoxicity
  • Use with corticosteroids causes hypokalemia
  • Increases risk of digoxin toxicity
  • Can increase risk of lithium toxicity
  • NSAIDs - Decrease diuretic action
  • Antidiabetic drugs - Decreases diuretic action

Hydrochlorothiazide

Indications

  • Treatment of edema, DI, HTN

Contraindications

  • Allergy
  • Hepatic coma
  • Anuria
  • Severe renal failure

Adverse effects

  • Hypokalemia
  • Hyponatremia
  • Hypercalcemia, hyperlipidemia, hyperglycemia, hyperuricemia

Nursing Considerations

  • Monitor for electrolyte imbalances
  • Antidiabetic drugs - Enhances hypoglycemia
  • Corticosteroids - Hypokalemia
  • Digoxin or lithium - Toxicity
  • NSAIDs - Decreased diuretic effect

Anemia drugs - Ferrous Sulfate

Indications

  • Supplement

Contraindications

  • Allergy, hemochromatosis, hemolytic anemia, anemia not associated with iron-deficiency

Adverse Effects

  • N,V, D, constipation, stomach cramps or pain.

Nursing considerations

  • Use straw to avoid teeth discoloration
  • Drink plenty of fluids on an empty stomach
  • Avoid antacids or milk
  • Drink with vitamin C to enhance absorption
  • Take between meals
  • Patient remains upright or sitting up for 30 min. after taking iron
  • Stool color changes to brown/tarry color - Increase fluid intake